The interaction of ETV6 (TEL) and TIP60 requires a functional histone acetyltransferase domain in TIP60

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 11-12, 2007, Pages 1211-1224

  Putnik, Jasmina ^c   Zhang, Chang Dong ^a,b   Archangelo, Leticia Fröhlich ^a,b   Tizazu, Belay ^a,b   Bartels, Sigrun ^c   Kickstein, Michael ^c   Greif, Philipp A ^a,b   Bohlander, Stefan K ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Institute of Human Genetics   (Germany)

Author keywords

ETV6; MORF; MOZ; TIP60

Indexed keywords

HISTONE ACETYLTRANSFERASE; ISOENZYME; TAT INTERACTING PROTEIN 60; TRANSCRIPTION FACTOR ETV6; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; CELL NUCLEUS; CONTROLLED STUDY; FLUORESCENCE; GENETIC TRANSFECTION; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; TWO HYBRID SYSTEM;

AMINO ACID SEQUENCE; ANIMALS; GENE REGULATORY NETWORKS; HELA CELLS; HISTONE ACETYLTRANSFERASES; HUMANS; HYDROXAMIC ACIDS; MATRIX METALLOPROTEINASE 3; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; SEQUENCE ALIGNMENT; SUBCELLULAR FRACTIONS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 36849053896     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2007.09.006     Document Type: Article

References (73)

1. Kobayashi H., Montgomery K.T., Bohlander S.K., Adra C.N., Lim B.L., Kucherlapati R.S., Donis-Keller H., Holt M.S., Le Beau M.M., and Rowley J.D. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases. Blood 84 (1994) 3473-3482
2. Mitelman F. Catalog of Chromosome Aberrations in Cancer (1994), Alan R. Liss, New York
3. Sato Y., Bohlander S.K., Kobayashi H., Reshmi S., Suto Y., Davis E.M., Espinosa III R., Hoopes R., Montgomery K., Kucherlapati R.S., Le Beau M.M., and Rowley J.D. Heterogeneity in the breakpoint in balanced rearrangements involving band 12p13 in hematologic malignancies identified by fluorescence in situ hybridization: TEL(ETV6) is involved in only one half. Blood 90 (1997) 4886-4893
4. Rowley J.D. The role of chromosome translocations in leukemogenesis. Semin. Hematol. 36 (1999) 59-72
5. Golub T.R., Barker G.F., Lovett M., and Gilliland D.G. Fusion of PDGF receptor b to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77 (1994) 307-316
6. Bohlander S.K. ETV6: a versatile player in leukemogenesis. Semin. Cancer Biol. 15 (2005) 162-174
7. Vu H.A., Xinh P.T., Masuda M., Motoji T., Toyoda A., Sakaki Y., Tokunaga K., and Sato Y. FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation. Leukemia 20 (2006) 1414-1421
8. Suto Y., Sato Y., Smith S.D., Rowley J.D., and Bohlander S.K. A t(6;12)(q23;p13) results in the fusion of ETV6 to a novel gene, STL, in a B-cell ALL cell line. Genes Chromosomes Cancer 18 (1997) 254-268
9. Yagasaki F., Jinnai I., Yoshida S., Yokoyama Y., Matsuda A., Kusumoto S., Kobayashi H., Terasaki H., Ohyashiki K., Asou N., Murohashi I., Bessho M., and Hirashima K. Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5;12)(q31;p13). Genes Chromosomes Cancer 26 (1999) 192-202
10. Chase A., Reiter A., Burci L., Cazzaniga G., Biondi A., Pickard J., Roberts I.A., Goldman J.M., and Cross N.C. Fusion of ETV6 to the caudal-related homeobox gene CDX2 in acute myeloid leukemia with the t(12;13)(p13;q12). Blood 93 (1999) 1025-1031
11. Rawat V.P.S., Cusan M., Deshpande A., Hiddemann W., Quintanilla-Fend L., Humphries R.K., Bohlander S.K., Feuring-Buske M., and Buske C. Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 817-822
12. Golub T.R., Barker G.F., Bohlander S.K., Hiebert S.W., Ward D.C., Bray-Ward P., Morgan E., Raimondi S.C., Rowley J.D., and Gilliland D.G. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 4917-4921
13. Shurtleff S.A., Buijs A., Behm F.G., Rubnitz J.E., Raimondi S.C., Hancock M.L., Chan G.C.-F., Pui C.-H., Grosveld G., and Downing J.R. Tel/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9 (1995) 1985-1989
14. Cave H., Cacheux V., Raynaud S., Brunie G., Bakkus M., Cochaux P., Preudhomme C., Lai J.L., Vilmer E., and Grandchamp B. ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia. Leukemia 11 (1997) 1459-1464
15. Sato Y., Suto Y., Pietenpol J., Golub T.R., Gilliland D.G., Davis E.M., Le Beau M.M., Roberts J.M., Vogelstein B., Rowley J.D., and Bohlander S.K. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood 86 (1995) 1525-1533
16. Wlodarska I., Marynen P., La Starza R., Mecucci C., and Van den Berghe H. The ETV6, CDKN1B and D12S178 loci are involved in a segment commonly deleted in various 12p aberration in different hematological malignancies. Cytogenet. Cell Genet. 72 (1996) 229-235
17. Wang L.C., Kuo F., Fujiwara Y., Gilliland D.G., Golub T.R., and Orkin S.H. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 16 (1997) 4374-4383
18. Wang L.C., Swat W., Fujiwara Y., Davidson L., Visvader J., Kuo F., Alt F.W., Gilliland D.G., Golub T.R., and Orkin S.H. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev. 12 (1998) 2392-2402
19. Hock H., Meade E., Medeiros S., Schindler J.W., Valk P.J., Fujiwara Y., and Orkin S.H. Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. Genes Dev. 18 (2004) 2336-2341
20. Gavaravarapu S., and Kamine J. Tip60 inhibits activation of CREB protein by protein kinase A. Biochem. Biophys. Res. Commun. 269 (2000) 758-766
21. Shi Y., Seto E., Chang L.S., and Shenk T. Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell 67 (1991) 377-388
22. Fenrick R., Wang L., Nip J., Amann J.M., Rooney R.J., Walker-Daniels J., Crawford H.C., Hulboy D.L., Kinch M.S., Matrisian L.M., and Hiebert S.W. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Mol. Cell Biol. 20 (2000) 5828-5839
23. Schluter G., Boinska D., and Nieman-Seyde S.-C. Evidence for translational repression of the SOCS-1 major open reading frame by an upstream open reading frame. Biochem. Biophys. Res. Commun. 268 (2000) 255-261
24. G. Behre, L.T. Smith and D.G. Tenen, Use of a promoterless Renilla luciferase vector as an internal control plasmid for transient co-transfection assays of Ras-mediated transcription activation, Biotechniques 26 (1999) 24-6, 28.
25. Netzer C., Rieger L., Brero A., Zhang C.D., Hinzke M., Kohlhase J., and Bohlander S.K. SALL1, the gene mutated in Townes-Brocks syndrome, encodes a transcriptional repressor which interacts with TRF1/PIN2 and localizes to pericentromeric heterochromatin. Hum. Mol. Genet. 10 (2001) 3017-3024
26. Shen Z., Pardington P.P., Comeaux J.C., Moyzis R.K., and Chen D.J. Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system. Genomics 37 (1996) 183-186
27. Kamine J., Elangovan B., Subramanian T., Coleman D., and Chinnadurai G. Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. Virology 216 (1996) 357-366
28. Ran Q., and Pereira S.O. Identification of an alternatively spliced form of the Tat interactive protein (Tip60), Tip60(beta). Gene 258 (2000) 141-146
29. Chakrabarti S.R., and Nucifora G. The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A. Biochem. Biophys. Res. Commun. 264 (1999) 871-877
30. Nordentoft I., and Jorgensen P. The acetyltransferase 60 kDa trans-acting regulatory protein of HIV type 1-interacting protein (Tip60) interacts with the translocation E26 transforming-specific leukaemia gene (TEL) and functions as a transcriptional co-repressor. Biochem. J. 374 (2003) 165-173
31. Lopez R.G., Carron C., Oury C., Gardellin P., Bernard O., and Ghysdael J. TEL is a sequence-specific transcriptional repressor. J. Biol. Chem. 274 (1999) 30132-30138
32. Guidez F., Petrie K., Ford A.M., Lu H., Bennett C.A., MacGregor A., Hannemann J., Ito Y., Ghysdael J., Greaves M., Wiedemann L.M., and Zelent A. Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein. Blood 96 (2000) 2557-2561
33. Boccuni P., MacGrogan D., Scandura J.M., and Nimer S.D. The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6). J. Biol. Chem. 278 (2003) 15412-15420
34. Kwiatkowski B.A., Bastian L.S., Bauer T.J., Tsai S., Zielinska K.A., and Hickstein D.D. The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. J. Biol. Chem. 273 (1998) 17525-17530
35. Chakrabarti S.R., Sood R., Ganguly S., Bohlander S., Shen Z., and Nucifora G. Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7467-7472
36. Wood L.D., Irvin B.J., Nucifora G., Luce K.S., and Hiebert S.W. Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3257-3262
37. Chakrabarti S.R., Sood R., Nandi S., and Nucifora G. Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 13281-13285
38. Creaven M., Hans F., Mutskov V., Col E., Caron C., Dimitrov S., and Khochbin S. Control of the histone-acetyltransferase activity of Tip60 by the HIV-1 transactivator protein, Tat. Biochemistry 38 (1999) 8826-8830
39. Hilfiker A., Hilfiker K.D., Pannuti A., and Lucchesi J.C. mof, a putative acetyl transferase gene related to the Tip60 and MOZ human genes and to the SAS genes of yeast, is required for dosage compensation in Drosophila. EMBO J. 16 (1997) 2054-2060
40. Gold D.A., Baek S.H., Schork N.J., Rose D.W., Larsen D.D., Sachs B.D., Rosenfeld M.G., and Hamilton B.A. RORalpha coordinates reciprocal signaling in cerebellar development through sonic hedgehog and calcium-dependent pathways. Neuron 40 (2003) 1119-1131
41. Sapountzi V., Logan I.R., and Robson C.N. Cellular functions of TIP60. Int. J. Biochem. Cell Biol. 38 (2006) 1496-1509
42. Cao X., and Sudhof T.C. A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293 (2001) 115-120
43. Xiao H., Chung J., Kao H.Y., and Yang Y.C. Tip60 is a co-repressor for STAT3. J. Biol. Chem. 278 (2003) 11197-11204
44. Kimura A., and Horikoshi M. Tip60 acetylates six lysines of a specific class in core histones in vitro. Genes Cells 3 (1998) 789-800
45. Brady M.E., Ozanne D.M., Gaughan L., Waite I., Cook S., Neal D.E., and Robson C.N. Tip60 is a nuclear hormone receptor coactivator. J. Biol. Chem. 274 (1999) 17599-17604
46. Lemercier C., Legube G., Caron C., Louwagie M., Garin J., Trouche D., and Khochbin S. Tip60 acetyltransferase activity is controlled by phosphorylation. J. Biol. Chem. 278 (2003) 4713-4718
47. Gaughan L., Logan I.R., Cook S., Neal D.E., and Robson C.N. Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor. J. Biol. Chem. 277 (2002) 25904-25913
48. Hlubek F., Lohberg C., Meiler J., Jung A., Kirchner T., and Brabletz T. Tip60 is a cell-type-specific transcriptional regulator. J. Biochem. (Tokyo) 129 (2001) 635-641
49. Ikura T., Ogryzko V.V., Grigoriev M., Groisman R., Wang J., Horikoshi M., Scully R., Qin J., and Nakatani Y. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 102 (2000) 463-473
50. Legube G., Linares L.K., Lemercier C., Scheffner M., Khochbin S., and Trouche D. Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation. EMBO J. 21 (2002) 1704-1712
51. Kusch T., Florens L., Macdonald W.H., Swanson S.K., Glaser R.L., Yates III J.R., Abmayr S.M., Washburn M.P., and Workman J.L. Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science 306 (2004) 2084-2087
52. Logan I.R., Sapountzi V., Gaughan L., Neal D.E., and Robson C.N. Control of human Pirh2 protein stability-involvement of TIP60 and the proteosome. J. Biol. Chem. (2003)
53. Frank S.R., Parisi T., Taubert S., Fernandez P., Fuchs M., Chan H.M., Livingston D.M., and Amati B. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep. 4 (2003) 575-580
54. Baek S.H., Ohgi K.A., Rose D.W., Koo E.H., Glass C.K., and Rosenfeld M.G. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110 (2002) 55-67
55. Kim J.H., Kim B., Cai L., Choi H.J., Ohgi K.A., Tran C., Chen C., Chung C.H., Huber O., Rose D.W., Sawyers C.L., Rosenfeld M.G., and Baek S.H. Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature 434 (2005) 921-926
56. Reifsnyder C., Lowell J., Clarke A., and Pillus L. Yeast SAS silencing genes and human genes associated with AML and HIV-1 Tat interactions are homologous with acetyltransferases. Nat. Genet. 14 (1996) 42-49
57. Smith E.R., Eisen A., Gu W., Sattah M., Pannuti A., Zhou J., Cook R.G., Lucchesi J.C., and Allis C.D. ESA1 is a histone acetyltransferase that is essential for growth in yeast. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3561-3565
58. Brown C.E., Lechner T., Howe L., and Workman J.L. The many HATs of transcription coactivators. Trends Biochem. Sci. 25 (2000) 15-19
59. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
60. Borrow J., Stanton V.J., Andresen J.M., Becher R., Behm F.G., Chaganti R.S., Civin C.I., Disteche C., Dube I., Frischauf A.M., Horsman D., Mitelman F., Volinia S., Watmore A.E., and Housman D.E. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat. Genet. 14 (1996) 33-41
61. Carapeti M., Aguiar R.C., Goldman J.M., and Cross N.C. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood 91 (1998) 3127-3133
62. Liang J., Prouty L., Williams B.J., Dayton M.A., and Blanchard K.L. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2. Blood 92 (1998) 2118-2122
63. Chaffanet M., Gressin L., Preudhomme C., Soenen C.V., Birnbaum D., and Pebusque M.J. MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosomes Cancer 28 (2000) 138-144
64. Panagopoulos I., Fioretos T., Isaksson M., Samuelsson U., Billstrom R., Strombeck B., Mitelman F., and Johansson B. Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13). Hum. Mol. Genet. 10 (2001) 395-404
65. Champagne N., Bertos N.R., Pelletier N., Wang A.H., Vezmar M., Yang Y., Heng H.H., and Yang X.J. Identification of a human histone acetyltransferase related to monocytic leukemia zinc finger protein. J. Biol. Chem. 274 (1999) 28528-28536
66. Deguchi K., Ayton P.M., Carapeti M., Kutok J.L., Snyder C.S., Williams I.R., Cross N.C., Glass C.K., Cleary M.L., and Gilliland D.G. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell 3 (2003) 259-271
67. Bohlander S.K. Fusion genes in leukemia: an emerging network. Cytogenetics Cell Genetics 91 (2000) 52-56
68. Xiao S., Nalabolu S.R., Aster J.C., Ma J., Abruzzo L., Jaffe E.S., Stone R., Weissman S.M., Hudson T.J., and Fletcher J.A. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat. Genet. 18 (1998) 84-87
69. Reiter A., Sohal J., Kulkarni S., Chase A., Macdonald D.H., Aguiar R.C., Goncalves C., Hernandez J.M., Jennings B.A., Goldman J.M., and Cross N.C. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood 92 (1998) 1735-1742
70. Fioretos T., Panagopoulos I., Lassen C., Swedin A., Billstrom R., Isaksson M., Strombeck B., Olofsson T., Mitelman F., and Johansson B. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL. Genes Chromosomes Cancer 32 (2001) 302-310
71. Dreyling M.H., Martinez-Climent J.A., Zheng M., Mao J., Rowley J.D., and Bohlander S.K. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3-clathrin assembly protein family. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 4804-4809
72. Sadowski I., Ma J., Triezenberg S., and Ptashne M. GAL4-VP16 is an unusually potent transcriptional activator. Nature 335 (1988) 563-564
73. Smith D.B., and Johnson K.S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67 (1988) 31-40